ROYAL BANK OF CANADA - INMED PHARMACEUTICALS INC ownership

INMED PHARMACEUTICALS INC's ticker is INM and the CUSIP is 457637502. A total of 16 filers reported holding INMED PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of INMED PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$02500.0%0.00%
Q1 2022$0
-100.0%
250
-37.7%
0.00%
Q4 2021$1,000401
+60.4%
0.00%
Q3 2021$0
-100.0%
2500.0%0.00%
Q2 2021$1,000
-50.0%
250
-57.3%
0.00%
Q1 2021$2,000
+100.0%
586
+142.1%
0.00%
Q4 2020$1,0002420.00%
Other shareholders

There were no reported owners of INMED PHARMACEUTICALS INC in Q4 2020.

NameSharesValueWeighting ↓
View complete list of INMED PHARMACEUTICALS INC shareholders